nodes	percent_of_prediction	percent_of_DWPC	metapath
Tocainide—Lidocaine—EGFR—head and neck cancer	0.192	1	CrCbGaD
Tocainide—SCN10A—Developmental Biology—CEBPA—head and neck cancer	0.00783	0.00969	CbGpPWpGaD
Tocainide—SCN11A—L1CAM interactions—MAPK3—head and neck cancer	0.00781	0.00967	CbGpPWpGaD
Tocainide—CYP1A2—Xenobiotics—CYP1A1—head and neck cancer	0.00752	0.00931	CbGpPWpGaD
Tocainide—SCN11A—L1CAM interactions—MAPK1—head and neck cancer	0.00743	0.0092	CbGpPWpGaD
Tocainide—SCN11A—L1CAM interactions—EGFR—head and neck cancer	0.00743	0.0092	CbGpPWpGaD
Tocainide—CYP1A2—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00723	0.00895	CbGpPWpGaD
Tocainide—SCN8A—L1CAM interactions—MAPK3—head and neck cancer	0.00714	0.00885	CbGpPWpGaD
Tocainide—SCN8A—L1CAM interactions—MAPK1—head and neck cancer	0.0068	0.00842	CbGpPWpGaD
Tocainide—SCN8A—L1CAM interactions—EGFR—head and neck cancer	0.0068	0.00842	CbGpPWpGaD
Tocainide—SCN9A—L1CAM interactions—MAPK3—head and neck cancer	0.00578	0.00715	CbGpPWpGaD
Tocainide—CYP1A2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.00558	0.00691	CbGpPWpGaD
Tocainide—SCN3A—L1CAM interactions—MAPK3—head and neck cancer	0.00553	0.00684	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—CEBPA—head and neck cancer	0.0055	0.00681	CbGpPWpGaD
Tocainide—SCN9A—L1CAM interactions—MAPK1—head and neck cancer	0.0055	0.00681	CbGpPWpGaD
Tocainide—SCN9A—L1CAM interactions—EGFR—head and neck cancer	0.0055	0.00681	CbGpPWpGaD
Tocainide—ALB—Vitamin B12 Metabolism—SOD2—head and neck cancer	0.00538	0.00666	CbGpPWpGaD
Tocainide—SCN2A—L1CAM interactions—MAPK3—head and neck cancer	0.00531	0.00657	CbGpPWpGaD
Tocainide—SCN4A—L1CAM interactions—MAPK3—head and neck cancer	0.00531	0.00657	CbGpPWpGaD
Tocainide—SCN3A—L1CAM interactions—MAPK1—head and neck cancer	0.00526	0.00651	CbGpPWpGaD
Tocainide—SCN3A—L1CAM interactions—EGFR—head and neck cancer	0.00526	0.00651	CbGpPWpGaD
Tocainide—SCN10A—L1CAM interactions—MAPK3—head and neck cancer	0.00512	0.00634	CbGpPWpGaD
Tocainide—SCN1A—L1CAM interactions—MAPK3—head and neck cancer	0.00512	0.00634	CbGpPWpGaD
Tocainide—SCN2A—L1CAM interactions—MAPK1—head and neck cancer	0.00505	0.00626	CbGpPWpGaD
Tocainide—SCN4A—L1CAM interactions—MAPK1—head and neck cancer	0.00505	0.00626	CbGpPWpGaD
Tocainide—SCN2A—L1CAM interactions—EGFR—head and neck cancer	0.00505	0.00625	CbGpPWpGaD
Tocainide—SCN4A—L1CAM interactions—EGFR—head and neck cancer	0.00505	0.00625	CbGpPWpGaD
Tocainide—CYP1A2—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.00492	0.00609	CbGpPWpGaD
Tocainide—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	0.00491	0.00608	CbGpPWpGaD
Tocainide—SCN1A—L1CAM interactions—MAPK1—head and neck cancer	0.00487	0.00603	CbGpPWpGaD
Tocainide—SCN10A—L1CAM interactions—MAPK1—head and neck cancer	0.00487	0.00603	CbGpPWpGaD
Tocainide—SCN1A—L1CAM interactions—EGFR—head and neck cancer	0.00487	0.00603	CbGpPWpGaD
Tocainide—SCN10A—L1CAM interactions—EGFR—head and neck cancer	0.00487	0.00603	CbGpPWpGaD
Tocainide—ALB—Folate Metabolism—SOD2—head and neck cancer	0.00438	0.00542	CbGpPWpGaD
Tocainide—SCN7A—Developmental Biology—NOTCH1—head and neck cancer	0.00427	0.00529	CbGpPWpGaD
Tocainide—ALB—Folate Metabolism—GPX1—head and neck cancer	0.00418	0.00517	CbGpPWpGaD
Tocainide—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	0.00386	0.00478	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.00386	0.00478	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.00386	0.00478	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—NOTCH1—head and neck cancer	0.00381	0.00471	CbGpPWpGaD
Tocainide—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.00365	0.00452	CbGpPWpGaD
Tocainide—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.00361	0.00447	CbGpPWpGaD
Tocainide—SCN5A—L1CAM interactions—MAPK3—head and neck cancer	0.0036	0.00446	CbGpPWpGaD
Tocainide—SCN7A—Axon guidance—VEGFA—head and neck cancer	0.0035	0.00434	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—NOTCH1—head and neck cancer	0.00348	0.00431	CbGpPWpGaD
Tocainide—ALB—Selenium Micronutrient Network—SOD2—head and neck cancer	0.00348	0.00431	CbGpPWpGaD
Tocainide—SCN5A—L1CAM interactions—MAPK1—head and neck cancer	0.00342	0.00424	CbGpPWpGaD
Tocainide—SCN5A—L1CAM interactions—EGFR—head and neck cancer	0.00342	0.00424	CbGpPWpGaD
Tocainide—ALB—Selenium Micronutrient Network—GPX1—head and neck cancer	0.00332	0.00411	CbGpPWpGaD
Tocainide—SCN7A—Axon guidance—MAPK3—head and neck cancer	0.00331	0.0041	CbGpPWpGaD
Tocainide—SCN7A—Axon guidance—MAPK1—head and neck cancer	0.00315	0.0039	CbGpPWpGaD
Tocainide—SCN7A—Axon guidance—EGFR—head and neck cancer	0.00315	0.0039	CbGpPWpGaD
Tocainide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00312	0.00386	CbGpPWpGaD
Tocainide—SCN11A—Axon guidance—VEGFA—head and neck cancer	0.00312	0.00386	CbGpPWpGaD
Tocainide—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00308	0.00381	CbGpPWpGaD
Tocainide—SCN11A—Axon guidance—MAPK3—head and neck cancer	0.00295	0.00366	CbGpPWpGaD
Tocainide—CYP1A2—Biological oxidations—NAT2—head and neck cancer	0.00287	0.00355	CbGpPWpGaD
Tocainide—SCN8A—Axon guidance—VEGFA—head and neck cancer	0.00285	0.00353	CbGpPWpGaD
Tocainide—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	0.00283	0.00351	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—NOTCH1—head and neck cancer	0.00282	0.00349	CbGpPWpGaD
Tocainide—SCN11A—Axon guidance—MAPK1—head and neck cancer	0.00281	0.00348	CbGpPWpGaD
Tocainide—SCN11A—Axon guidance—EGFR—head and neck cancer	0.00281	0.00348	CbGpPWpGaD
Tocainide—SCN8A—Axon guidance—MAPK3—head and neck cancer	0.0027	0.00334	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—NOTCH1—head and neck cancer	0.00269	0.00334	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—NOTCH1—head and neck cancer	0.00259	0.0032	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—NOTCH1—head and neck cancer	0.00259	0.0032	CbGpPWpGaD
Tocainide—SCN5A—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.00258	0.0032	CbGpPWpGaD
Tocainide—SCN8A—Axon guidance—MAPK1—head and neck cancer	0.00257	0.00318	CbGpPWpGaD
Tocainide—SCN8A—Axon guidance—EGFR—head and neck cancer	0.00257	0.00318	CbGpPWpGaD
Tocainide—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00253	0.00313	CbGpPWpGaD
Tocainide—SCN7A—Axon guidance—HRAS—head and neck cancer	0.00253	0.00313	CbGpPWpGaD
Tocainide—SCN7A—Developmental Biology—VEGFA—head and neck cancer	0.0025	0.00309	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—NOTCH1—head and neck cancer	0.0025	0.00309	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—NOTCH1—head and neck cancer	0.0025	0.00309	CbGpPWpGaD
Tocainide—SCN7A—Developmental Biology—STAT3—head and neck cancer	0.00247	0.00306	CbGpPWpGaD
Tocainide—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	0.00242	0.003	CbGpPWpGaD
Tocainide—SCN7A—Developmental Biology—MAPK3—head and neck cancer	0.00236	0.00293	CbGpPWpGaD
Tocainide—SCN9A—Axon guidance—VEGFA—head and neck cancer	0.00231	0.00286	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.0023	0.00284	CbGpPWpGaD
Tocainide—ALB—Folate Metabolism—IL2—head and neck cancer	0.00228	0.00282	CbGpPWpGaD
Tocainide—SCN11A—Axon guidance—HRAS—head and neck cancer	0.00225	0.00279	CbGpPWpGaD
Tocainide—SCN7A—Developmental Biology—MAPK1—head and neck cancer	0.00225	0.00278	CbGpPWpGaD
Tocainide—SCN7A—Developmental Biology—EGFR—head and neck cancer	0.00225	0.00278	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—VEGFA—head and neck cancer	0.00223	0.00276	CbGpPWpGaD
Tocainide—SCN3A—Axon guidance—VEGFA—head and neck cancer	0.00221	0.00273	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—STAT3—head and neck cancer	0.0022	0.00273	CbGpPWpGaD
Tocainide—SCN9A—Axon guidance—MAPK3—head and neck cancer	0.00218	0.0027	CbGpPWpGaD
Tocainide—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.00215	0.00266	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.00213	0.00263	CbGpPWpGaD
Tocainide—SCN4A—Axon guidance—VEGFA—head and neck cancer	0.00212	0.00263	CbGpPWpGaD
Tocainide—SCN2A—Axon guidance—VEGFA—head and neck cancer	0.00212	0.00263	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—MAPK3—head and neck cancer	0.00211	0.00261	CbGpPWpGaD
Tocainide—SCN3A—Axon guidance—MAPK3—head and neck cancer	0.00209	0.00259	CbGpPWpGaD
Tocainide—SCN9A—Axon guidance—MAPK1—head and neck cancer	0.00208	0.00257	CbGpPWpGaD
Tocainide—SCN9A—Axon guidance—EGFR—head and neck cancer	0.00208	0.00257	CbGpPWpGaD
Tocainide—SCN8A—Axon guidance—HRAS—head and neck cancer	0.00206	0.00255	CbGpPWpGaD
Tocainide—SCN1A—Axon guidance—VEGFA—head and neck cancer	0.00205	0.00253	CbGpPWpGaD
Tocainide—SCN10A—Axon guidance—VEGFA—head and neck cancer	0.00205	0.00253	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—VEGFA—head and neck cancer	0.00204	0.00252	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—STAT3—head and neck cancer	0.00202	0.0025	CbGpPWpGaD
Tocainide—SCN2A—Axon guidance—MAPK3—head and neck cancer	0.00201	0.00248	CbGpPWpGaD
Tocainide—SCN4A—Axon guidance—MAPK3—head and neck cancer	0.00201	0.00248	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—MAPK1—head and neck cancer	0.002	0.00248	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—EGFR—head and neck cancer	0.002	0.00248	CbGpPWpGaD
Tocainide—SCN3A—Axon guidance—MAPK1—head and neck cancer	0.00199	0.00246	CbGpPWpGaD
Tocainide—SCN3A—Axon guidance—EGFR—head and neck cancer	0.00199	0.00246	CbGpPWpGaD
Tocainide—ALB—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.00195	0.00242	CbGpPWpGaD
Tocainide—SCN10A—Axon guidance—MAPK3—head and neck cancer	0.00193	0.0024	CbGpPWpGaD
Tocainide—SCN1A—Axon guidance—MAPK3—head and neck cancer	0.00193	0.0024	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—MAPK3—head and neck cancer	0.00193	0.00239	CbGpPWpGaD
Tocainide—SCN2A—Axon guidance—MAPK1—head and neck cancer	0.00191	0.00236	CbGpPWpGaD
Tocainide—SCN4A—Axon guidance—MAPK1—head and neck cancer	0.00191	0.00236	CbGpPWpGaD
Tocainide—SCN2A—Axon guidance—EGFR—head and neck cancer	0.00191	0.00236	CbGpPWpGaD
Tocainide—SCN4A—Axon guidance—EGFR—head and neck cancer	0.00191	0.00236	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.0019	0.00235	CbGpPWpGaD
Tocainide—SCN10A—Axon guidance—MAPK1—head and neck cancer	0.00184	0.00228	CbGpPWpGaD
Tocainide—SCN1A—Axon guidance—MAPK1—head and neck cancer	0.00184	0.00228	CbGpPWpGaD
Tocainide—SCN1A—Axon guidance—EGFR—head and neck cancer	0.00184	0.00228	CbGpPWpGaD
Tocainide—SCN10A—Axon guidance—EGFR—head and neck cancer	0.00184	0.00228	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—MAPK1—head and neck cancer	0.00183	0.00227	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—EGFR—head and neck cancer	0.00183	0.00227	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.00181	0.00224	CbGpPWpGaD
Tocainide—SCN7A—Developmental Biology—HRAS—head and neck cancer	0.00181	0.00224	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—NOTCH1—head and neck cancer	0.00175	0.00217	CbGpPWpGaD
Tocainide—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—head and neck cancer	0.00171	0.00212	CbGpPWpGaD
Tocainide—ALB—Metabolism—UROD—head and neck cancer	0.00169	0.00209	CbGpPWpGaD
Tocainide—SCN9A—Axon guidance—HRAS—head and neck cancer	0.00167	0.00207	CbGpPWpGaD
Tocainide—ALB—Platelet degranulation—VEGFA—head and neck cancer	0.00166	0.00206	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—VEGFA—head and neck cancer	0.00165	0.00204	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—STAT3—head and neck cancer	0.00163	0.00202	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.00163	0.00202	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	0.00163	0.00202	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.00163	0.00202	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—HRAS—head and neck cancer	0.00161	0.00199	CbGpPWpGaD
Tocainide—SCN3A—Axon guidance—HRAS—head and neck cancer	0.0016	0.00198	CbGpPWpGaD
Tocainide—SCN7A—Developmental Biology—AKT1—head and neck cancer	0.00159	0.00197	CbGpPWpGaD
Tocainide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—head and neck cancer	0.00158	0.00196	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—VEGFA—head and neck cancer	0.00158	0.00195	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—STAT3—head and neck cancer	0.00156	0.00193	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—MAPK3—head and neck cancer	0.00156	0.00193	CbGpPWpGaD
Tocainide—SCN2A—Axon guidance—HRAS—head and neck cancer	0.00153	0.0019	CbGpPWpGaD
Tocainide—SCN4A—Axon guidance—HRAS—head and neck cancer	0.00153	0.0019	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—VEGFA—head and neck cancer	0.00151	0.00187	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—VEGFA—head and neck cancer	0.00151	0.00187	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—STAT3—head and neck cancer	0.0015	0.00186	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—STAT3—head and neck cancer	0.0015	0.00186	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—MAPK3—head and neck cancer	0.00149	0.00185	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—MAPK1—head and neck cancer	0.00148	0.00184	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—EGFR—head and neck cancer	0.00148	0.00184	CbGpPWpGaD
Tocainide—SCN10A—Axon guidance—HRAS—head and neck cancer	0.00148	0.00183	CbGpPWpGaD
Tocainide—SCN1A—Axon guidance—HRAS—head and neck cancer	0.00148	0.00183	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—HRAS—head and neck cancer	0.00147	0.00182	CbGpPWpGaD
Tocainide—ALB—Folate Metabolism—TP53—head and neck cancer	0.00146	0.00181	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—VEGFA—head and neck cancer	0.00146	0.00181	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—VEGFA—head and neck cancer	0.00146	0.00181	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—STAT3—head and neck cancer	0.00145	0.00179	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—STAT3—head and neck cancer	0.00145	0.00179	CbGpPWpGaD
Tocainide—SCN5A—Axon guidance—VEGFA—head and neck cancer	0.00144	0.00178	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—MAPK3—head and neck cancer	0.00143	0.00177	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—MAPK3—head and neck cancer	0.00143	0.00177	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—AKT1—head and neck cancer	0.00142	0.00176	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—MAPK1—head and neck cancer	0.00142	0.00176	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—EGFR—head and neck cancer	0.00142	0.00176	CbGpPWpGaD
Tocainide—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	0.00142	0.00176	CbGpPWpGaD
Tocainide—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	0.0014	0.00173	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—MAPK3—head and neck cancer	0.00138	0.00171	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—MAPK3—head and neck cancer	0.00138	0.00171	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—MAPK1—head and neck cancer	0.00136	0.00169	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—MAPK1—head and neck cancer	0.00136	0.00169	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—EGFR—head and neck cancer	0.00136	0.00169	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—EGFR—head and neck cancer	0.00136	0.00169	CbGpPWpGaD
Tocainide—SCN5A—Axon guidance—MAPK3—head and neck cancer	0.00136	0.00168	CbGpPWpGaD
Tocainide—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	0.00134	0.00166	CbGpPWpGaD
Tocainide—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	0.00133	0.00164	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—MAPK1—head and neck cancer	0.00131	0.00163	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—MAPK1—head and neck cancer	0.00131	0.00163	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—EGFR—head and neck cancer	0.00131	0.00163	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—EGFR—head and neck cancer	0.00131	0.00163	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.00131	0.00162	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	0.00131	0.00162	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—AKT1—head and neck cancer	0.0013	0.00161	CbGpPWpGaD
Tocainide—SCN5A—Axon guidance—MAPK1—head and neck cancer	0.00129	0.0016	CbGpPWpGaD
Tocainide—SCN5A—Axon guidance—EGFR—head and neck cancer	0.00129	0.0016	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—HRAS—head and neck cancer	0.00119	0.00147	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—UROD—head and neck cancer	0.00118	0.00146	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—HRAS—head and neck cancer	0.00114	0.00141	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—HRAS—head and neck cancer	0.00109	0.00135	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—HRAS—head and neck cancer	0.00109	0.00135	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—HRAS—head and neck cancer	0.00105	0.00131	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—HRAS—head and neck cancer	0.00105	0.00131	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—AKT1—head and neck cancer	0.00105	0.0013	CbGpPWpGaD
Tocainide—SCN5A—Axon guidance—HRAS—head and neck cancer	0.00104	0.00129	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—VEGFA—head and neck cancer	0.00103	0.00127	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—STAT3—head and neck cancer	0.00102	0.00126	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—AKT1—head and neck cancer	0.00101	0.00124	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—MAPK3—head and neck cancer	0.000971	0.0012	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—AKT1—head and neck cancer	0.000966	0.0012	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—AKT1—head and neck cancer	0.000966	0.0012	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—AKT1—head and neck cancer	0.000931	0.00115	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—AKT1—head and neck cancer	0.000931	0.00115	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—MAPK1—head and neck cancer	0.000924	0.00114	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—EGFR—head and neck cancer	0.000923	0.00114	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000917	0.00114	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—IL2—head and neck cancer	0.000867	0.00107	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000745	0.000923	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—HRAS—head and neck cancer	0.000741	0.000918	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000738	0.000914	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	0.000737	0.000912	CbGpPWpGaD
Tocainide—ALB—Metabolism—NAT2—head and neck cancer	0.000702	0.000869	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	0.000697	0.000863	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	0.000663	0.000821	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—AKT1—head and neck cancer	0.000655	0.000811	CbGpPWpGaD
Tocainide—ALB—Metabolism—DPYD—head and neck cancer	0.000615	0.000762	CbGpPWpGaD
Tocainide—ALB—Metabolism—YAP1—head and neck cancer	0.000584	0.000723	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	0.000575	0.000712	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000521	0.000646	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000516	0.000639	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—NAT2—head and neck cancer	0.000491	0.000608	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	0.00047	0.000582	CbGpPWpGaD
Tocainide—ALB—Hemostasis—IL2—head and neck cancer	0.000447	0.000553	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000439	0.000543	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—DPYD—head and neck cancer	0.00043	0.000533	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—YAP1—head and neck cancer	0.000408	0.000506	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000383	0.000474	CbGpPWpGaD
Tocainide—ALB—Hemostasis—VEGFA—head and neck cancer	0.00038	0.00047	CbGpPWpGaD
Tocainide—ALB—Hemostasis—MAPK3—head and neck cancer	0.000359	0.000445	CbGpPWpGaD
Tocainide—ALB—Metabolism—TYMS—head and neck cancer	0.000351	0.000434	CbGpPWpGaD
Tocainide—ALB—Metabolism—GSTM1—head and neck cancer	0.000347	0.000429	CbGpPWpGaD
Tocainide—ALB—Hemostasis—MAPK1—head and neck cancer	0.000342	0.000423	CbGpPWpGaD
Tocainide—ALB—Metabolism—GPX1—head and neck cancer	0.000332	0.000411	CbGpPWpGaD
Tocainide—ALB—Metabolism—CYP1A1—head and neck cancer	0.000329	0.000407	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000307	0.00038	CbGpPWpGaD
Tocainide—ALB—Hemostasis—PIK3CA—head and neck cancer	0.000297	0.000367	CbGpPWpGaD
Tocainide—ALB—Hemostasis—TP53—head and neck cancer	0.000287	0.000355	CbGpPWpGaD
Tocainide—ALB—Hemostasis—HRAS—head and neck cancer	0.000274	0.00034	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.00027	0.000334	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000268	0.000331	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—TYMS—head and neck cancer	0.000245	0.000304	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—GSTM1—head and neck cancer	0.000242	0.0003	CbGpPWpGaD
Tocainide—ALB—Hemostasis—AKT1—head and neck cancer	0.000242	0.0003	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—GPX1—head and neck cancer	0.000232	0.000288	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—CYP1A1—head and neck cancer	0.00023	0.000285	CbGpPWpGaD
Tocainide—ALB—Metabolism—PTGS2—head and neck cancer	0.000195	0.000242	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000189	0.000234	CbGpPWpGaD
Tocainide—ALB—Metabolism—PTEN—head and neck cancer	0.00017	0.000211	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—PTGS2—head and neck cancer	0.000137	0.000169	CbGpPWpGaD
Tocainide—ALB—Metabolism—PIK3CA—head and neck cancer	0.00012	0.000149	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—PTEN—head and neck cancer	0.000119	0.000148	CbGpPWpGaD
Tocainide—ALB—Metabolism—AKT1—head and neck cancer	9.82e-05	0.000122	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—PIK3CA—head and neck cancer	8.41e-05	0.000104	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—AKT1—head and neck cancer	6.87e-05	8.51e-05	CbGpPWpGaD
